Medication info
Glupa Tablets 1,000 mg (Metformin Hydrochloride)

Glupa Tablets 1,000 mg (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
(Darim Biotech Co., Ltd.)
Appearance
White rectangular film-coated tablet
Packaging
Domestic: 500 tablets/bottle, 100 tablets/bottle, 30 tablets/bottle, Export: 500 tablets/bottle, 60 tablets/bottle, 60 tablets (10 tablets/PTPX6)
Approval status
Active

MFDS item code 200101317 · Notified 2001.12.03 · Insurance code 664600070

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dosage should be determined individually based on drug efficacy and tolerability, and should not exceed the recommended maximum daily dose. This drug must be initiated at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control. Administer 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses per day, taken in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 doses per day and administer with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to this drug and determine the minimum effective dose. Measure blood glycated hemoglobin levels at approximately 3-month intervals. The goal of treatment with this drug, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is controlled by diet alone but becomes temporarily uncontrolled, short-term treatment with this drug may be sufficient to achieve an adequate effect. This drug may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other conditions that may increase the risk of lactic acidosis, with the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, divided into 2 doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73㎡, respectively, administration of this drug must be discontinued immediately.
Child dose
Children aged 10 years and older or adolescents who are growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Ingredients

Manufacturer
(Darim Biotech Co., Ltd.)

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 Diabetes
View approved original text

This medication is used to treat patients with Type 2 diabetes who have insufficient blood sugar control through diet and exercise alone. It is particularly effective in overweight adult patients and can be used alone or in combination with other oral hypoglycemic agents or insulin. Additionally, it can be used in children aged 10 years and older, either as monotherapy or in combination with insulin. Therefore, this medication is employed to assist in blood sugar control and improve treatment in patients with diabetes across a variety of ages and conditions.

How to take

Adult dose

The dosage should be determined individually based on drug efficacy and tolerability, and should not exceed the recommended maximum daily dose. This drug must be initiated at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control. Administer 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses per day, taken in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 doses per day and administer with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to this drug and determine the minimum effective dose. Measure blood glycated hemoglobin levels at approximately 3-month intervals. The goal of treatment with this drug, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is controlled by diet alone but becomes temporarily uncontrolled, short-term treatment with this drug may be sufficient to achieve an adequate effect. This drug may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other conditions that may increase the risk of lactic acidosis, with the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, divided into 2 doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73㎡, respectively, administration of this drug must be discontinued immediately.

Child dose

Children aged 10 years and older or adolescents who are growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, thus caution is necessary. It should not be administered to patients with moderate to severe renal impairment, dehydration, or serious infections and cardiovascular problems. Patients with acute heart failure or those receiving iodine-based contrast agents used for specific radiological exams should also avoid this medication. It should not be given to patients with allergic reactions to this drug or similar classes of medications, to Type 1 diabetes patients, or to patients with acute or chronic metabolic acidosis. Patients with severe infections or traumatic systemic disorders may need to temporarily discontinue this medication, and patients scheduled for surgery should stop 48 hours prior. Those with poor nutritional status, liver dysfunction, or excessive drinking should use this medication with caution. Irregular eating or intense exercise, as well as interactions with other medications, may lead to lactic acidosis or hypoglycemia during treatment with this drug. Lactic acidosis, though rare, is a very serious side effect; symptoms such as fatigue, muscle pain, breathing difficulties, or abdominal pain require immediate consultation with a physician. Gastrointestinal symptoms can be common during initial treatment but are usually temporary and can be alleviated by taking the medication with meals or gradually increasing the dose. This medication is primarily excreted through the kidneys, so regular kidney function tests are necessary, and the medication should be discontinued if kidney function significantly declines. Alcohol can increase the risk of side effects from this medication, so excessive consumption should be avoided. During pregnancy, it may affect the fetus, so it is essential to consult a physician, and if breastfeeding, the decision to use it should also be made after consulting with a specialist. Elderly patients and children require careful dosing adjustments and monitoring. When used in combination with other medications, it may alter blood sugar control, so any ongoing medications should be disclosed to healthcare providers. In cases of overdose, blood dialysis may be required, so immediate emergency care should be sought if overdose is suspected. This medication does not cause weight gain and may actually aid in weight management, but regular monitoring of blood glucose and blood tests is necessary to confirm treatment efficacy and safety.

Side effects

  • lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver dysfunction
  • severe delayed hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius. Proper storage will help preserve the medication's efficacy.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

Domestic: 500 tablets/bottle, 100 tablets/bottle, 30 tablets/bottle, Export: 500 tablets/bottle, 60 tablets/bottle, 60 tablets (10 tablets/PTPX6)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.